Literature DB >> 6162241

HLA-DRw antigens associated with acute leukemia.

V E von Fliedner, Z Sultan-Khan, M Jeannet.   

Abstract

In mice, susceptibility to leukemia is closely linked to "Ia" antigens coded by the major histocompatibility complex and is transmitted recessively. To test this hypothesis in man, 89 patients with acute leukemia were typed for the eight known HLA-DRw specificities, representing the human counterpart of the Ia system, and compared with a normal unrelated control population (n=123). Phenotypes showing only one identifiable DRw antigen were significantly increased in patients with acute leukemia. Within such phenotypes, there was a predominant and significant occurrence of DRw antigens 3, 6, and 7, depending on the type of leukemia (AML, ALL in adults, and ALL in children respectively). These findings are most probably due to an excess of homozygotes for these particular DRw antigens, thus suggesting a recessive mode of transmission of susceptibility to leukemia in man.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6162241     DOI: 10.1111/j.1399-0039.1980.tb00321.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  4 in total

1.  Human leukocyte antigen-DRB1 polymorphism in childhood acute lymphoblastic leukemia.

Authors:  Mervat M El Ansary; Lamiaa A Mohammed; Tamer H Hassan; Ahmed Baraka; Alshymaa A Ahmed
Journal:  Mol Clin Oncol       Date:  2014-11-25

2.  Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope.

Authors:  S Seremetis; J Cuttner; R Winchester
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

3.  Absence of HLA association or linkage for variations in sensitivity to the odor of androstenone.

Authors:  M S Pollack; C J Wysocki; G K Beauchamp; D Braun; C Callaway; B Dupont
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

Review 4.  Genetic variation in the extended major histocompatibility complex and susceptibility to childhood acute lymphoblastic leukemia: a review of the evidence.

Authors:  Kevin Y Urayama; Pamela D Thompson; Malcolm Taylor; Elizabeth A Trachtenberg; Anand P Chokkalingam
Journal:  Front Oncol       Date:  2013-12-12       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.